Retrospective Chart Review to Evaluate the Safety Profile of Ceftobiprole in Patients With Impaired Hepatic or Renal Function or Immunosuppression (RETRACE)
OBSERVATIONAL STUDY WITH MEDICATION
Clinical trial information
- Promoter: ADVANZ PHARMA SWITZERLAND SARL
- Execution start: 07/12/2022
- End of execution: 31/12/2023
- PI: CARMEN HIDALGO TENORIO